| Lead Manager/ | # of | Price Range | Dollar | SCOOP | ||
| New Filings (Proposed Symbol) | Joint-Lead Managers | Shares | Low | High | Volume | Ratings |
| Alteryx (AYX) | Goldman, Sachs/ J.P. Morgan | $75.00 | n.a. | |||
| n.a. (not available) | ||||||
| Postponed | ||||||
| None | ||||||
| Withdrawn | ||||||
| Braeburn Pharmaceuticals (BBRX) | J.P. Morgan/ BofA Merrill Lynch | 7.69 | $18.00 | $21.00 | $150.00 | 1-Star |
| New Terms | ||||||
| None | ||||||
| IPOs Priced | Lead | Shares | Amount | Offer | Close | % |
| Week of Feb. 20, 2017 | Manager(s) | Offered | Raised | Price | 2/24/17 | Change |
| None |
